Cellebrite DI Ltd. Form 6-K Summary
Business Context and Reporting Period
Cellebrite DI Ltd., a foreign private issuer based in Petah Tikva, Israel, filed this Form 6-K on September 1, 2023. The filing serves to update the Company's registration statement on Form F-3 by attaching consolidated financial statements and an operating and financial review for the six months ended June 30, 2023.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The filing explicitly states that the consolidated financial statements and operating review are attached as exhibits (Exhibit 99.1 and 99.2) rather than being detailed within the cover text of this Form 6-K.
Material Changes
The filing text does not provide data to compare current period performance against prior periods. Specific material changes in financial position or results of operations are contained within the attached exhibits referenced in the filing.
Guidance, Outlook, and Risks
The filing includes an "Operating and Financial Review and Prospects" for the six months ended June 30, 2023, as Exhibit 99.2. However, the cover text does not summarize specific guidance, management commentary, risks, contingencies, or unusual items. The document notes that this Form 6-K is incorporated by reference into the Company's registration statements on Form S-8 and Form F-3.
Investor Verification Checklist
- Review Exhibit 99.1 for the actual consolidated financial statements for the six months ended June 30, 2023.
- Examine Exhibit 99.2 for the detailed operating and financial review, including any management commentary or outlook.
- Verify the incorporation by reference into the active Form S-8 and Form F-3 registration statements.
- Confirm the unaudited status of the financial data presented in the attached exhibits.